跳至主要内容
临床试验/NCT04304092
NCT04304092撤回不适用

Addressing Individual Variability in Response to Exercise

Dr. Robert Ross0 个研究点开始时间: 2022年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
主要终点
Change in Cardiorespiratory Fitness

研究概览

简要总结

In this proposal, the investigators challenge the assumption that following the physical activity guidelines implies benefit for ALL adults, and that if benefit is not achieved in response to first line therapy, it will be by simply exercising more. Thus, for improving cardiorespiratory fitness and cardiometabolic risk factors, unanswered questions include: 1) To what extent, regardless of exercise amount or intensity, is exercise not associated with benefit? Demonstration of a resistance to benefit through exercise in a substantial number of adults would be a novel and important finding, would counter the assumptions of many if not most health care practitioners, and could have immediate and direct application in all health care settings. 2) To what extent will non-responders to first line therapy (150 min/wk) be required to increase exercise amount or intensity to achieve benefit? 3) To what extent will failure to improve CRF segregate (be associate with) with cardiometabolic risk factors? The investigators propose that adults who remain exercise resistant for improvement in CRF and cardiometabolic risk despite increasing amount or intensity are at high risk of metabolic disease and consequently, are candidates for alternative treatment strategies. 4) To what extent is biological sex and/or phenotype a determinant of response or non-response to exercise?

详细描述

The trial has three objectives:

Primary objective: Determine whether alterations in exercise amount and intensity improves the rate of clinically meaningful improvements in aerobic exercise capacity as measured by cardiorespiratory fitness (CRF, VO2peak) among adults.

Secondary objective: Determine whether common cardiometabolic risk factors segregate with respect to variation in CRF to first line therapy in adults, and, whether clinically meaningful improvements in cardiometabolic risk factors segregate with associated improvement in CRF.

Tertiary objective: Identify whether biological sex and/or phenotype are determinants of variation in CRF and cardiometabolic risk factors in response to first line therapy, and, whether they predict variability in CRF response to alterations in exercise dose.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

exercise trial, no blinding

入排标准

年龄范围
25 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Sedentary lifestyle (planned physical activity for one day per week or less).
  • •Weight stable (± 2 kg) for 6 months prior to the beginning of the study.
  • •BMI between 20 and 40 kg/m2.

排除标准

  • •Physical impairment which would make the intervention very difficult or unsafe according to doctor's advice.
  • •Diabetes, current smokers.
  • •Plan to move from the area in next 8 months.

研究组 & 干预措施

Low amount, low intensity

Experimental

干预措施: Exercise (Other)

Low amount, high intensity

Experimental

干预措施: Exercise (Other)

High Amount, low intensity

Experimental

干预措施: Exercise (Other)

High Amount, high intensity

Experimental

干预措施: Exercise (Other)

Control

No Intervention

结局指标

主要结局

Change in Cardiorespiratory Fitness

时间窗: Measured at baseline and every 4 weeks for 32 weeks.

Cardiorespiratory fitness will be determined using direct (open circuit spirometry) measures of oxygen consumption (expressed in L/min) obtained during a maximal treadmill test.

次要结局

  • Change in cardiometabolic risk factors(Measured at baseline, 16 and 32 weeks.)
  • Change in cardiometabolic risk factor(Measured at baseline, 16 and 32 weeks.)

研究者

发起方
Dr. Robert Ross
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr. Robert Ross

Professor

Queen's University

相似试验